Primary Penile Tumor Diagnosis and Initial Management
Authored by Asif Muneer, published on 2026-11-03 23:00:16.0
The algorithm is broadly consistent with contemporary guidance favoring stage- and extent-adapted penile-preserving treatment when oncologically feasible. Its treatment branches closely reflect the 2024 ESMO-EURACAN primary-tumor algorithm, but the evidence is predominantly retrospective and expert-consensus based. Important omissions include explicit biopsy confirmation, margin and recurrence-surveillance principles, and concurrent risk-adapted inguinal nodal staging.
Primary Penile Tumour
Current multidisciplinary guidance supports individualized management that balances complete tumor control against preservation of urinary, sexual, and cosmetic function. The 2026 update continues to emphasize nuanced organ-preserving strategies and centralized care.
Clinical And Radiological Assessment
TIS Or TA
Penile-Preserving Treatment
Circumcision plus WLE [IV, A] OR Topical ChT or immunotherapy [IV, B] OR Laser therapy [IV, B] OR Partial/total glans resurfacing [IV, A]
T1 Or T2 Glans
Small Lesions
Local Treatment For Small Lesions
Circumcision and WLE [IV, A] OR Laser therapy [IV, B] OR WLE with partial glans resurfacing [IV, A]
Large Or Multifocal Lesions
Treatment For Large Or Multifocal Lesions
Glansectomy with or without grafting [III, A] OR Glansectomy with distal urethrectomy [III, A] OR Brachytherapy and/or EBRT [III, B]
T2–T4 With Limited Or Cavernosal Involvement
Treatment For Cavernosal Involvement
Glansectomy with distal corporectomy [III, A] OR Partial penectomy [IV, A] OR Total penectomy [IV, A] OR Brachytherapy and/or EBRT [III, B]